New data reveals a striking disparity in how individuals respond to identical vitamin D supplementation based on their starting vitamin D levels. According to findings from a large community-based analysis of 3,667 adults, the same 1,000 IU daily dose produces an 11 ng/mL increase in individuals with deficient baseline levels, but only a 5 ng/mL increase in those with adequate baseline status. This two-fold difference in response magnitude illustrates why standardized dosing recommendations fail to account for individual variation in vitamin D metabolism. The research demonstrates that a person’s current serum 25-hydroxyvitamin D level is a critical predictor of how effectively supplementation will raise their blood levels. These findings have profound implications for clinical practice, suggesting that baseline testing should precede supplementation decisions to optimize therapeutic outcomes and avoid both under- and over-supplementation.
Was this article helpful?
